Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001388410-18-000038
Filing Date
2018-08-29
Accepted
2018-08-29 16:53:20
Documents
6
Period of Report
2017-06-30
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT 20170630prlxform10qfinal.htm 10-Q 893389
2 EX 31.1 SEC 302 CERTIFICATION-CEO ex311sect302certceo063017.htm EX-31 7469
3 EX 31.2 SEC 302 CERTIFICATION-CFO ex312sect302certcfo063017.htm EX-31 7477
4 EX 32.1 SEC 906 CERTIFICATION-CEO ex321sect906certceo063017.htm EX-32 4353
5 EX 32.2 SEC 906 CERTIFICATION-CFO ex322sect906certcfo063017.htm EX-32 4234
12 IMAGE f20170630prlxform10qfinal1.jpg GRAPHIC 58416
  Complete submission text file 0001388410-18-000038.txt   998792
Mailing Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401
Business Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401 310-899-4442
PARALLAX HEALTH SCIENCES, INC. (Filer) CIK: 0001388410 (see all company filings)

EIN.: 464733512 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52534
SIC: 5912 Retail-Drug Stores and Proprietary Stores